End-of-day quote
Shanghai S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
10.43
CNY
|
-1.70%
|
|
-1.32%
|
-22.57%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
12,503
|
6,652
|
4,255
|
3,744
|
5,961
|
6,899
|
Enterprise Value (EV)
1 |
12,089
|
4,905
|
3,430
|
3,888
|
6,902
|
7,703
|
P/E ratio
|
9.74
x
|
6.71
x
|
92.8
x
|
101
x
|
26.7
x
|
16.3
x
|
Yield
|
1.18%
|
1.24%
|
0.17%
|
0.17%
|
0.42%
|
1.83%
|
Capitalization / Revenue
|
2.83
x
|
1.5
x
|
2.02
x
|
2.26
x
|
2.5
x
|
1.4
x
|
EV / Revenue
|
2.74
x
|
1.11
x
|
1.63
x
|
2.35
x
|
2.89
x
|
1.57
x
|
EV / EBITDA
|
5.61
x
|
2.73
x
|
15.7
x
|
22.8
x
|
14.4
x
|
8.23
x
|
EV / FCF
|
9.2
x
|
4.08
x
|
-11.9
x
|
-7.66
x
|
-5.06
x
|
54.3
x
|
FCF Yield
|
10.9%
|
24.5%
|
-8.43%
|
-13.1%
|
-19.8%
|
1.84%
|
Price to Book
|
4.56
x
|
1.85
x
|
1.2
x
|
1.05
x
|
1.57
x
|
1.75
x
|
Nbr of stocks (in thousands)
|
411,864
|
411,864
|
411,864
|
411,864
|
418,596
|
418,356
|
Reference price
2 |
30.36
|
16.15
|
10.33
|
9.090
|
14.24
|
16.49
|
Announcement Date
|
4/9/18
|
3/28/19
|
4/23/20
|
4/9/21
|
4/21/22
|
4/26/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
4,417
|
4,432
|
2,106
|
1,653
|
2,387
|
4,914
|
EBITDA
1 |
2,156
|
1,796
|
218.9
|
170.7
|
480
|
935.6
|
EBIT
1 |
1,885
|
1,504
|
-34.15
|
-79.96
|
200.8
|
504.3
|
Operating Margin
|
42.68%
|
33.94%
|
-1.62%
|
-4.84%
|
8.41%
|
10.26%
|
Earnings before Tax (EBT)
1 |
1,793
|
1,356
|
-6.511
|
10.62
|
216.4
|
457.6
|
Net income
1 |
1,283
|
990.9
|
45.84
|
36.94
|
220.3
|
420.1
|
Net margin
|
29.05%
|
22.36%
|
2.18%
|
2.23%
|
9.23%
|
8.55%
|
EPS
2 |
3.115
|
2.406
|
0.1113
|
0.0897
|
0.5333
|
1.012
|
Free Cash Flow
1 |
1,314
|
1,202
|
-289.3
|
-507.8
|
-1,365
|
141.9
|
FCF margin
|
29.74%
|
27.11%
|
-13.74%
|
-30.71%
|
-57.19%
|
2.89%
|
FCF Conversion (EBITDA)
|
60.93%
|
66.91%
|
-
|
-
|
-
|
15.16%
|
FCF Conversion (Net income)
|
102.4%
|
121.26%
|
-
|
-
|
-
|
33.77%
|
Dividend per Share
2 |
0.3571
|
0.2000
|
0.0180
|
0.0150
|
0.0600
|
0.3020
|
Announcement Date
|
4/9/18
|
3/28/19
|
4/23/20
|
4/9/21
|
4/21/22
|
4/26/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
-
|
144
|
942
|
804
|
Net Cash position
1 |
414
|
1,747
|
824
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
0.8457
x
|
1.962
x
|
0.8594
x
|
Free Cash Flow
1 |
1,314
|
1,202
|
-289
|
-508
|
-1,365
|
142
|
ROE (net income / shareholders' equity)
|
61.8%
|
30.6%
|
0.66%
|
0.34%
|
4.96%
|
10.4%
|
ROA (Net income/ Total Assets)
|
29.1%
|
21%
|
-0.45%
|
-0.88%
|
1.86%
|
4.52%
|
Assets
1 |
4,404
|
4,721
|
-10,272
|
-4,185
|
11,870
|
9,295
|
Book Value Per Share
2 |
6.660
|
8.710
|
8.600
|
8.680
|
9.040
|
9.410
|
Cash Flow per Share
2 |
1.760
|
4.310
|
3.170
|
2.650
|
1.020
|
1.000
|
Capex
1 |
51.9
|
76.2
|
526
|
1,108
|
2,048
|
402
|
Capex / Sales
|
1.17%
|
1.72%
|
24.97%
|
67%
|
85.8%
|
8.18%
|
Announcement Date
|
4/9/18
|
3/28/19
|
4/23/20
|
4/9/21
|
4/21/22
|
4/26/23
|
|
1st Jan change
|
Capi.
|
---|
| -22.57% | 600M | | -1.20% | 66.01B | | +47.62% | 41.76B | | +15.99% | 38.66B | | +4.25% | 32.28B | | +8.78% | 19.57B | | +12.32% | 16.77B | | +17.69% | 15.08B | | +8.31% | 14.83B | | -14.59% | 13.95B |
Other Commodity Chemicals
|